These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7837152)

  • 21. T cell activation in vivo by dengue virus infection.
    Kurane I; Innis BL; Hoke CH; Eckels KH; Meager A; Janus J; Ennis FA
    J Clin Lab Immunol; 1995; 46(1):35-40. PubMed ID: 9363590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic variables in normal pregnancy and spontaneous abortion.
    Matalliotakis I; Neonaki M; Giannakopoulou C; Goumenou A; Hassan E; Koumantakis E
    Int J Fertil Womens Med; 1998; 43(5):262-6. PubMed ID: 9863620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus.
    Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR
    J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble IL-2-receptor and CD8 in the serum and the periparasitic granuloma of patients with alveolar echinococcosis.
    Bresson-Hadni S; Monnot-Jacquard B; Racadot E; Lenys D; Miguet JP; Vuitton DA
    Eur Cytokine Netw; 1991; 2(5):339-44. PubMed ID: 1804323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
    Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
    Uchio E; Matsumoto T; Tanaka SI; Ohno S
    Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
    Salvarani C; Cantini F; Niccoli L; Catanoso MG; Macchioni P; Pulsatelli L; Padula A; Olivieri I; Boiardi L
    J Rheumatol; 2003 Apr; 30(4):760-3. PubMed ID: 12672196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
    Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
    van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
    J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
    Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
    Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
    Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower concentration of serum soluble CD8 in severe Hashimoto's disease.
    Yamamoto N; Watanabe M; Matsuzuka F; Miyauchi A; Iwatani Y
    Clin Exp Immunol; 2004 Sep; 137(3):601-5. PubMed ID: 15320913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD; Engel EE; Charley MR; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
    Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
    Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
    Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
    Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of measuring soluble interleukin-2 receptor in polymyalgia rheumatica.
    Gripenberg M; Franzén P; Fröseth B
    Scand J Rheumatol; 1995; 24(1):26-8. PubMed ID: 7863274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.